These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29355613)

  • 1. Histopathological growth patterns as a candidate biomarker for immunomodulatory therapy.
    van Dam PJ; Daelemans S; Ross E; Waumans Y; Van Laere S; Latacz E; Van Steen R; De Pooter C; Kockx M; Dirix L; Vermeulen PB
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):86-93. PubMed ID: 29355613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications and mechanism of histopathological growth pattern in colorectal cancer liver metastases.
    Kong BT; Fan QS; Wang XM; Zhang Q; Zhang GL
    World J Gastroenterol; 2022 Jul; 28(26):3101-3115. PubMed ID: 36051338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International consensus guidelines for scoring the histopathological growth patterns of liver metastasis.
    van Dam PJ; van der Stok EP; Teuwen LA; Van den Eynden GG; Illemann M; Frentzas S; Majeed AW; Eefsen RL; Coebergh van den Braak RRJ; Lazaris A; Fernandez MC; Galjart B; Laerum OD; Rayes R; Grünhagen DJ; Van de Paer M; Sucaet Y; Mudhar HS; Schvimer M; Nyström H; Kockx M; Bird NC; Vidal-Vanaclocha F; Metrakos P; Simoneau E; Verhoef C; Dirix LY; Van Laere S; Gao ZH; Brodt P; Reynolds AR; Vermeulen PB
    Br J Cancer; 2017 Nov; 117(10):1427-1441. PubMed ID: 28982110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological growth pattern and vessel co-option in intrahepatic cholangiocarcinoma.
    Li Z; Nguyen Canh H; Takahashi K; Le Thanh D; Nguyen Thi Q; Yang R; Yoshimura K; Sato Y; Nguyen Thi K; Nakata H; Ikeda H; Kozaka K; Kobayashi S; Yagi S; Harada K
    Med Mol Morphol; 2024 Sep; 57(3):200-217. PubMed ID: 38960952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineating the molecular landscape of different histopathological growth patterns in colorectal cancer liver metastases.
    Hu M; Chen Z; Hu D; Xi S; Wang D; Zhang X; Fong WP; Wen L; Cai Y; Yuan Y; Li B; Wu X; Lu Z; Chen G; Li L; Ding P; Pan Z; Wan D; Du Z; Chen M; Li Y
    Front Immunol; 2022; 13():1045329. PubMed ID: 36591262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.
    Bridgeman VL; Vermeulen PB; Foo S; Bilecz A; Daley F; Kostaras E; Nathan MR; Wan E; Frentzas S; Schweiger T; Hegedus B; Hoetzenecker K; Renyi-Vamos F; Kuczynski EA; Vasudev NS; Larkin J; Gore M; Dvorak HF; Paku S; Kerbel RS; Dome B; Reynolds AR
    J Pathol; 2017 Feb; 241(3):362-374. PubMed ID: 27859259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological growth patterns of neuroendocrine tumor liver metastases.
    Meyer Y; Bohlok A; Olthof P; Donckier V; Doukas M; Lucidi V; Vermeulen P; Grünhagen D; Verhoef C
    Clin Exp Metastasis; 2023 Jun; 40(3):227-234. PubMed ID: 37183203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological growth pattern evolution of tumor in VX2 liver cancer model.
    Kong B; Zhou J; Wang H; Li Y; Pan Y; Zhu H; Zhang Q; Fan Q; Wang X; Zhang G
    Pathol Res Pract; 2023 Apr; 244():154401. PubMed ID: 36905696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights.
    Latacz E; Höppener D; Bohlok A; Leduc S; Tabariès S; Fernández Moro C; Lugassy C; Nyström H; Bozóky B; Floris G; Geyer N; Brodt P; Llado L; Van Mileghem L; De Schepper M; Majeed AW; Lazaris A; Dirix P; Zhang Q; Petrillo SK; Vankerckhove S; Joye I; Meyer Y; Gregorieff A; Roig NR; Vidal-Vanaclocha F; Denis L; Oliveira RC; Metrakos P; Grünhagen DJ; Nagtegaal ID; Mollevi DG; Jarnagin WR; D'Angelica MI; Reynolds AR; Doukas M; Desmedt C; Dirix L; Donckier V; Siegel PM; Barnhill R; Gerling M; Verhoef C; Vermeulen PB
    Br J Cancer; 2022 Oct; 127(6):988-1013. PubMed ID: 35650276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophils expressing lysyl oxidase-like 4 protein are present in colorectal cancer liver metastases resistant to anti-angiogenic therapy.
    Palmieri V; Lazaris A; Mayer TZ; Petrillo SK; Alamri H; Rada M; Jarrouj G; Park WY; Gao ZH; McDonald PP; Metrakos P
    J Pathol; 2020 Jun; 251(2):213-223. PubMed ID: 32297656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different Forms of Tumor Vascularization and Their Clinical Implications Focusing on Vessel Co-option in Colorectal Cancer Liver Metastases.
    Haas G; Fan S; Ghadimi M; De Oliveira T; Conradi LC
    Front Cell Dev Biol; 2021; 9():612774. PubMed ID: 33912554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive cells in tumor immune escape and metastasis.
    Liu Y; Cao X
    J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-Derived Exosomes and Their Role in Cancer Progression.
    Whiteside TL
    Adv Clin Chem; 2016; 74():103-41. PubMed ID: 27117662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Structural changes of tumor microenvironment in liver metastases of colorectal carcinoma].
    Giuşcă SE; Carasevici E; Eloae-Zugun F; Târcoveanu E; Căruntu ID
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(1):165-73. PubMed ID: 18677922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-2 as a Biomarker and Target for Immune Checkpoint Therapy.
    Wu X; Giobbie-Hurder A; Liao X; Connelly C; Connolly EM; Li J; Manos MP; Lawrence D; McDermott D; Severgnini M; Zhou J; Gjini E; Lako A; Lipschitz M; Pak CJ; Abdelrahman S; Rodig S; Hodi FS
    Cancer Immunol Res; 2017 Jan; 5(1):17-28. PubMed ID: 28003187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can medical imaging identify the histopathological growth patterns of liver metastases?
    Latacz E; van Dam PJ; Vanhove C; Llado L; Descamps B; Ruiz N; Joye I; Grünhagen D; Van Laere S; Dirix P; Mollevi DG; Verhoef C; Dirix L; Vermeulen P
    Semin Cancer Biol; 2021 Jun; 71():33-41. PubMed ID: 32735852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological growth pattern of liver metastases as an independent marker of metastatic behavior in different primary cancers.
    Bohlok A; Richard F; Lucidi V; Asmar AE; Demetter P; Craciun L; Larsimont D; Hendlisz A; Van Laethem JL; Dirix L; Desmedt C; Vermeulen P; Donckier V
    Front Oncol; 2023; 13():1260880. PubMed ID: 37965465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution.
    Fleischer JR; Schmitt AM; Haas G; Xu X; Zeisberg EM; Bohnenberger H; Küffer S; Teuwen LA; Karras PJ; Beißbarth T; Bleckmann A; Planque M; Fendt SM; Vermeulen P; Ghadimi M; Kalucka J; De Oliveira T; Conradi LC
    Mol Cancer; 2023 Jan; 22(1):17. PubMed ID: 36691028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological Growth Patterns Determine the Outcomes of Colorectal Cancer Liver Metastasis Following Liver Resection.
    Krzywoń L; Lazaris A; Petrillo SK; Zlotnik O; Gao ZH; Metrakos P
    Cancers (Basel); 2024 Sep; 16(18):. PubMed ID: 39335120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging biomarkers for immunomodulatory cancer treatment of upper gastrointestinal, pancreatic and hepatic cancers.
    Lee B; Hutchinson R; Wong HL; Tie J; Putoczki T; Tran B; Gibbs P; Christie M
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):241-252. PubMed ID: 29258858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.